← Leaderboards
Sue Elizabeth Kim
Yale University
$1,142,566
Attributed
$10,946,000
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $7.3M · FY2024–25$10M$7.5M$5M$2.5M$0
'24
'25
Funding mix
By agency
NIH$10,946,000 · 1
By mechanism
OT2$10,946,000 · 1
Top collaborators
- Alexander D Borowsky4 shared
- Marc T Goodman4 shared
- Robert A Hiatt4 shared
- Daniella Meeker4 shared
- Janitza Liz Montalvo-Ortiz4 shared
- Lucila Ohno-Machado4 shared
- Amarilys Silva4 shared
- Amy Montague Sitapati4 shared
Most similar at Yale University
Same institution · by research overlap
- Lucila Ohno-Machado$130,482,087
- Dylan Grace Gee$6,747,368
- Eli Lebowitz$2,898,951
- Cynthia Ann Brandt$12,415,934
- Amarilys Silva$1,142,566
Others in their field
Other Rising Stars on “Life Cycle Stages”
- Cathie Snyder · Rho Federal Systems Division, Inc.$13,836,971
- Daniel Hunter Reirden · Westat, Inc.$11,343,255
- Peter N. Schmidt · Rho Federal Systems Division, Inc.$9,313,989
- Michael Hogarth · University Of California, San Diego$9,300,393
- Nancy Glenn · Boise State University$8,000,000
- Mignonne Catherine Guy · Univ Of Arkansas For Med Scis$6,026,320
Research focus
Life Cycle StagesPrecision HealthElectronic Health RecordInstitutionMonitorParticipantCostDecision MakingEquilibriumInnovationMemberMissionMultidisciplinaryOutreachCollectionCatchment AreaAll Of Us Research ProgramData ExchangeBiomedical ResearchEnrollmentImplementation ScienceInfrastructureMeasurementPrecision Medicine
Grant awards (4)
All of Us Coast-to-Coast Strong recrUitment, Retention, and Facilitation (C2C SURF)$3,646,000
OT2 · FY2025 · OD
All of Us Coast-to-Coast Strong recrUitment, Retention, and Facilitation (C2C SURF)$5,600,000
OT2 · FY2024 · OD
Enhancing All of Us through the Targeted Enrollment of Opioid Use Disorder Special Populations$1,250,000
OT2 · FY2024 · OD
Ocular Image Study for All of Us at Yale and UCSD$450,000
OT2 · FY2024 · OD